Fanny Mochel

This inventor holds 7 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: National Institute of Health and Medical Research, Baylor Research Institute, Assistance Publique - Hopitaux De Paris (Aphp). Active years: 2015-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fanny Mochel. Retrieved from https://idiyas.com/inventor/fanny-mochel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 7 (Patent Applications = 7)

% Patents Active = 85.7

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 103(Granted Patents)

Location History:

Dallas, TX (US) (2015 - 2017)
Saint Maur des Fosses, FR (2017 - 2019)
Paris, FR (2016 - 2021)

Company Filing History:

5 out of 1,853

National Institute of Health and Medical Research

patents

3 out of 96

Baylor Research Institute

patents

1 out of 79

Assistance Publique - Hopitaux De Paris (Aphp)

patents

4. 1 out of 5,383

Centre National De La Recherche Scientifique

patents

5. 1 out of 6

Ecole Pratique Des Hautes Etudes

patents

6. 1 out of 9

Icm-Institut Du Cerveau Et De La Moelle Epiniere

8. 1 out of 834,659

Other

patents

where one patent can have more than one assignee

Years Active: 2015-2021

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11065238 - Inhibitors of gangliosides metabolism for the treatment of motor neuron diseases (2021-07-20),

2. 10220014 - Anaplerotic therapy of huntington disease and other polyglutamine diseases (2019-03-05),

3. 10111848 - Triheptanoin for the treatment of glucose transport 1 deficiency (2018-10-30),

4. 9750732 - Urinary triaosylceramide (Gb3) as a marker of cardiac disease (2017-09-05),

5. 9717705 - Anaplerotic therapy of huntington disease and other polyglutamine diseases (2017-08-01),

6. 9468229 - Triheptanoin for the treatment of glucose transport 1 deficiency (2016-10-18),

7. 9066939 - Urinary triaosylceramide (GB3) as a marker of cardiac disease (2015-06-30),

Title: The Innovative Mind of Fanny Mochel

Introduction: Fanny Mochel, a pioneering inventor hailing from Paris, France, has made significant contributions to the world of technology and innovation.

Latest Patents: Fanny Mochel's latest patents focus on sustainable energy solutions and cutting-edge advancements in artificial intelligence.

Career Highlights: Throughout her illustrious career, Fanny Mochel has been recognized for her groundbreaking work in the fields of renewable energy, robotics, and smart technology.

Collaborations: Fanny Mochel has collaborated with leading research institutions and tech companies to bring her innovative ideas to life, pushing the boundaries of what is possible in the world of invention.

Conclusion: Fanny Mochel's passion for innovation and her relentless pursuit of excellence continue to inspire inventors and entrepreneurs around the globe.

Profile summary based on public USPTO records.